Which side effect is associated with the use of etomidate as an IV anesthetic?

Which side effect is associated with the use of etomidate as an IV anesthetic?

• A. Serotonin syndrome
• B. Postoperative nausea and vomiting
• C. Respiratory depression
• D. Cardiac dysrhythmias

Answer: (B)

The correct answer highlights postoperative nausea and vomiting as a side effect associated with the use of etomidate. While etomidate is favored for its minimal cardiovascular and respiratory effects, it still carries the risk of postoperative nausea and vomiting, which can occur after its use. This side effect is particularly relevant in the context of outpatient procedures, where nausea can complicate recovery. Etomidate has a different adverse profile compared to some other anesthetics, which might cause more significant respiratory depression or cardiovascular instability. Although respiratory depression, cardiac dysrhythmias, and serotonin syndrome are important considerations with various anesthetic agents, they are not predominantly linked with etomidate. Instead, etomidate's primary concern remains the incidence of nausea and vomiting during the recovery period following its administration.

The correct answer highlights postoperative nausea and vomiting as a side effect associated with the use of etomidate. While etomidate is favored for its minimal cardiovascular and respiratory effects, it still carries the risk of postoperative nausea and vomiting, which can occur after its use. This side effect is particularly relevant in the context of outpatient procedures, where nausea can complicate recovery.

Etomidate has a different adverse profile compared to some other anesthetics, which might cause more significant respiratory depression or cardiovascular instability. Although respiratory depression, cardiac dysrhythmias, and serotonin syndrome are important considerations with various anesthetic agents, they are not predominantly linked with etomidate. Instead, etomidate's primary concern remains the incidence of nausea and vomiting during the recovery period following its administration.